DK1083885T3 - Delavirdintabletformulering - Google Patents

Delavirdintabletformulering

Info

Publication number
DK1083885T3
DK1083885T3 DK99925951T DK99925951T DK1083885T3 DK 1083885 T3 DK1083885 T3 DK 1083885T3 DK 99925951 T DK99925951 T DK 99925951T DK 99925951 T DK99925951 T DK 99925951T DK 1083885 T3 DK1083885 T3 DK 1083885T3
Authority
DK
Denmark
Prior art keywords
delavirdine
tablet formulation
amount
superdisintegrant
binder
Prior art date
Application number
DK99925951T
Other languages
Danish (da)
English (en)
Inventor
Walter Morozowich
Alice C Martino
Ashley H Bates
E John Lee
Original Assignee
Pharmacia & Upjohn Co Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22214517&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1083885(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pharmacia & Upjohn Co Llc filed Critical Pharmacia & Upjohn Co Llc
Application granted granted Critical
Publication of DK1083885T3 publication Critical patent/DK1083885T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cephalosporin Compounds (AREA)
DK99925951T 1998-06-11 1999-06-07 Delavirdintabletformulering DK1083885T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US8896098P 1998-06-11 1998-06-11
PCT/US1999/011798 WO1999063970A1 (en) 1998-06-11 1999-06-07 Delavirdine tablet formulation

Publications (1)

Publication Number Publication Date
DK1083885T3 true DK1083885T3 (da) 2007-02-26

Family

ID=22214517

Family Applications (1)

Application Number Title Priority Date Filing Date
DK99925951T DK1083885T3 (da) 1998-06-11 1999-06-07 Delavirdintabletformulering

Country Status (21)

Country Link
US (3) US6177101B1 (ko)
EP (1) EP1083885B1 (ko)
JP (1) JP4827296B2 (ko)
KR (2) KR20070040426A (ko)
CN (1) CN1237958C (ko)
AT (1) ATE349203T1 (ko)
AU (1) AU753241C (ko)
BR (1) BR9910481A (ko)
CA (1) CA2328703C (ko)
CY (1) CY1105924T1 (ko)
DE (1) DE69934582T2 (ko)
DK (1) DK1083885T3 (ko)
EA (1) EA004311B1 (ko)
ES (1) ES2277682T3 (ko)
HK (1) HK1036417A1 (ko)
HU (1) HUP0102206A3 (ko)
NZ (1) NZ508762A (ko)
PL (1) PL200163B1 (ko)
PT (1) PT1083885E (ko)
WO (1) WO1999063970A1 (ko)
ZA (1) ZA200006090B (ko)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU753241C (en) * 1998-06-11 2003-05-08 Pharmacia & Upjohn Company Tablet formation
EP1712222A3 (en) 1999-12-23 2012-06-20 Pfizer Products Inc. Pharmaceutical compositions providing enhanced drug concentrations
US7115279B2 (en) 2000-08-03 2006-10-03 Curatolo William J Pharmaceutical compositions of cholesteryl ester transfer protein inhibitors
US20040243118A1 (en) * 2001-06-01 2004-12-02 Ayers Gregory M. Device and method for positioning a catheter tip for creating a cryogenic lesion
CA2458644A1 (en) * 2001-08-28 2003-03-13 Pharmacia Corporation Crystaline clindamycin free base
DE10164510A1 (de) * 2001-12-20 2003-07-10 Schering Ag Orale Fludara reinst Formulierung mit schneller Freisetzung des Wirkstoffes
JP2004107258A (ja) * 2002-09-18 2004-04-08 Ss Pharmaceut Co Ltd 催眠用圧縮成型製剤
AU2003230189A1 (en) * 2003-01-29 2004-08-23 Nitin Bhalachandra Dharmadhikari Oral controlled release pharmaceutical composition containing metaxalone as active agent
WO2004087175A1 (en) * 2003-04-04 2004-10-14 Pharmacia Corporation Oral extended release compressed tablets of multiparticulates
EP1635847B1 (en) 2003-06-13 2019-07-31 IDH Holding ApS Treatment of symptoms associated with bacterial vaginosis
CA2531116A1 (en) * 2003-07-01 2005-01-20 Michael Hawley Diffusion layer modulated solids
US7201920B2 (en) 2003-11-26 2007-04-10 Acura Pharmaceuticals, Inc. Methods and compositions for deterring abuse of opioid containing dosage forms
US20050283146A1 (en) * 2004-06-17 2005-12-22 Lentz David J Thermally extended spiral cryotip for a cryoablation catheter
US20060099253A1 (en) * 2004-10-20 2006-05-11 Wyeth Antibiotic product formulation
US20070059359A1 (en) * 2005-06-07 2007-03-15 Thomas Backensfeld Immediate-release and high-drug-load pharmaceutical formulations of non-micronised (4-chlorophenyl)[4-(4-pyridylmethyl)phthalazin-1-yl] and salts thereof
KR20110033311A (ko) 2006-07-27 2011-03-30 가부시키가이샤 고베 세이코쇼 접속 장치 및 이 접속 장치를 통해 접속되는 혼련 장치와 구동 장치를 갖는 혼련 설비
CA2617688C (en) * 2007-02-22 2015-08-18 Alpex Pharma S.A. Solid dosage formulations containing weight-loss drugs
US8696606B2 (en) * 2009-09-28 2014-04-15 Continuous MotionFlow, LLC Passive motion machine with integrated mechanical DVT prophylactic therapy
CA2775890C (en) 2009-09-30 2016-06-21 Acura Pharmaceuticals, Inc. Methods and compositions for deterring abuse
JP5226732B2 (ja) * 2010-05-20 2013-07-03 エスエス製薬株式会社 催眠用圧縮成型製剤
US20120010216A1 (en) * 2010-07-06 2012-01-12 Brown Arthur M Pharmaceutical compositions containing vanoxerine
US10201584B1 (en) 2011-05-17 2019-02-12 Abbvie Inc. Compositions and methods for treating HCV
JP6266635B2 (ja) 2012-10-18 2018-01-24 アッヴィ・インコーポレイテッド ピリミジンジオン誘導体化合物の製剤
MX366159B (es) 2012-11-30 2019-07-01 Acura Pharmaceuticals Inc Liberacion autorregulada de ingrediente farmaceutico activo.
NZ714963A (en) 2013-06-13 2020-07-31 Akebia Therapeutics Inc Compositions and methods for treating anemia
WO2015103490A1 (en) 2014-01-03 2015-07-09 Abbvie, Inc. Solid antiviral dosage forms
US11103581B2 (en) 2015-08-31 2021-08-31 Acura Pharmaceuticals, Inc. Methods and compositions for self-regulated release of active pharmaceutical ingredient
CA2937365C (en) 2016-03-29 2018-09-18 F. Hoffmann-La Roche Ag Granulate formulation of 5-methyl-1-phenyl-2-(1h)-pyridone and method of making the same
AU2019269815B2 (en) * 2018-05-15 2024-08-01 Jiangsu Hansoh Pharmaceutical Group Co., Ltd. Pharmaceutical composition comprising small molecule EGFR inhibitor and preparation method therefor
CN108619104A (zh) * 2018-06-29 2018-10-09 哈尔滨珍宝制药有限公司 一种基于盐酸克林霉素的药物组合物及其制备方法
CZ309820B6 (cs) * 2021-04-23 2023-11-08 Pro.Med.Cs Praha A.S. Způsob přípravy pevné lékové formy obsahující kompozici s nízkým obsahem účinné látky

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4013785A (en) * 1975-03-21 1977-03-22 Bristol-Myers Company Apap tablet containing fumed silica and process for manufacturing same
ZA855250B (en) * 1984-08-17 1986-02-26 Upjohn Co Stable,high dose,high bulk density ibuprofen granulations for tablet and capsule manufacturing
GB8521350D0 (en) * 1985-08-28 1985-10-02 Euro Celtique Sa Analgesic composition
DE3708916A1 (de) 1987-03-19 1988-09-29 Boehringer Ingelheim Kg Verfahren zur reinigung resorbierbarer polyester
ATE72118T1 (de) 1987-11-30 1992-02-15 Gist Brocades Nv Pharmazeutische zusammensetzung und verfahren zu ihrer herstellung.
US5211958A (en) * 1987-11-30 1993-05-18 Gist-Brocades, N.V. Pharmaceutical composition and process for its preparation
GB8824392D0 (en) * 1988-10-18 1988-11-23 Ciba Geigy Ag Dispersible formulation
US5256699A (en) * 1988-10-18 1993-10-26 Ciba-Geify Corporation Dispersible tablet formulation of diclofenac acid free base
CA2007764C (en) 1989-02-24 1999-11-30 Joseph Michael Beaurline Salsalate tablet
GB8909793D0 (en) * 1989-04-28 1989-06-14 Beecham Group Plc Pharmaceutical formulation
NZ236393A (en) 1989-12-13 1992-05-26 Lilly Co Eli N-alkylated glycopeptide derivatives prepared from antibiotics a82846 series and pa-42867-a; pharmaceutical compositions
US5563142A (en) * 1989-12-28 1996-10-08 The Upjohn Company Diaromatic substituted compounds as anti-HIV-1 agents
US5665720A (en) * 1992-08-07 1997-09-09 Merck & Co., Inc. Benzoxazinones as inhibitors of HIV reverse transcriptase
US5358941A (en) 1992-12-02 1994-10-25 Merck & Co., Inc. Dry mix formulation for bisphosphonic acids with lactose
FR2711524B1 (fr) * 1993-10-21 1995-11-24 Rhone Dpc Europ Procédé de préparation de compositions orales contenant des quinolones.
CA2184598C (en) 1994-04-15 2005-05-03 Jeffrey L. Havens Novel crystal forms of 1-[5-methanesulfonamidoindolyl-2-carbonyl]-4-[3-(1-methylethylamino)-2-pyridinyl]piperazine
US5585115A (en) * 1995-01-09 1996-12-17 Edward H. Mendell Co., Inc. Pharmaceutical excipient having improved compressability
US5837292A (en) * 1996-07-03 1998-11-17 Yamanouchi Europe B.V. Granulate for the preparation of fast-disintegrating and fast-dissolving compositions containing a high amount of drug
US6013280A (en) * 1997-10-07 2000-01-11 Fuisz Technologies Ltd. Immediate release dosage forms containing microspheres
US5955107A (en) * 1997-12-12 1999-09-21 Fmc Corporation Pharmaceutical suspension tablet compositions
UA72207C2 (uk) * 1998-04-07 2005-02-15 Брістол- Майєрс Сквібб Фарма Компані Фармацевтична композиція ефавіренцу з добавкою дезінтегруючих агентів у вигляді швидкорозчинних капсул або таблеток та спосіб її виготовлення
AU753241C (en) * 1998-06-11 2003-05-08 Pharmacia & Upjohn Company Tablet formation

Also Published As

Publication number Publication date
US6177101B1 (en) 2001-01-23
KR100724016B1 (ko) 2007-05-31
NZ508762A (en) 2003-07-25
KR20070040426A (ko) 2007-04-16
PT1083885E (pt) 2007-01-31
JP2002517430A (ja) 2002-06-18
KR20010052717A (ko) 2001-06-25
PL344328A1 (en) 2001-10-22
AU753241B2 (en) 2002-10-10
AU753241C (en) 2003-05-08
DE69934582T2 (de) 2007-10-04
HUP0102206A2 (hu) 2002-03-28
BR9910481A (pt) 2001-01-09
JP4827296B2 (ja) 2011-11-30
AU4213499A (en) 1999-12-30
US20060257476A1 (en) 2006-11-16
HK1036417A1 (en) 2002-01-04
HUP0102206A3 (en) 2002-12-28
WO1999063970A1 (en) 1999-12-16
DE69934582D1 (de) 2007-02-08
EA200100024A1 (ru) 2001-06-25
ATE349203T1 (de) 2007-01-15
CY1105924T1 (el) 2011-04-06
ES2277682T3 (es) 2007-07-16
ZA200006090B (en) 2001-10-29
CA2328703C (en) 2007-10-30
EP1083885B1 (en) 2006-12-27
EP1083885A1 (en) 2001-03-21
US7108864B1 (en) 2006-09-19
CN1301149A (zh) 2001-06-27
PL200163B1 (pl) 2008-12-31
EA004311B1 (ru) 2004-02-26
CA2328703A1 (en) 1999-12-16
CN1237958C (zh) 2006-01-25

Similar Documents

Publication Publication Date Title
DK1083885T3 (da) Delavirdintabletformulering
GEP20053420B (en) Sustained Release Ranolanolazine Formulation
BG105568A (en) Pharmaceutical compositions for modified release of an insulin sensitiser and another antidiabetic agent
GEP20012442B (en) Irreversible Inhibitors of Tyrosine Kinases
AU3080895A (en) Novel piperazides derived from arylpiperazine, processes for their preparation, their use as medicaments and pharmaceutical compositions comprising them
KR930016091A (ko) 거의 수불용성인 약제의 고체 분산액을 제조하는 방법
DK0730444T3 (da) Præparater med opretholdt frigivelse til 24-timers frigivelse af metoprolol.
HUP0100072A3 (en) Phenoxazine, phenthiazine derivatives, their use in medicine; process for their preparation and pharmaceutical compositions containing them
ES2094359T3 (es) Formulaciones farmaceuticas de proteinas osteogenicas.
CA2346001A1 (en) Controlled release nanoparticulate compositions
ATE145132T1 (de) Therapeutische zusammensetzung und verfahren für ihre herstellung
TR199901433T2 (xx) Pirolo$3,4-D] pirimidinon t�revleri ve bunlar�n ila� olarak kullan�mlar�.
GEP20033062B (en) Pharmaceutical Composition Comprising Entacapone or Nitecapone and Cross-Linked Cellulose Derivative
DE69632194D1 (de) Galanthamin-derivate, verfahren zu ihrer herstellung, ihre verwendung als arzmittel und diese enthaltende pharmazeutische zusammensetzung
BG105570A (en) Pharmaceutical compositions for modified release insulin sensitiser
TR200003303T2 (tr) Astıma, alerjiye, iltihaplanmaya karşı, bağışıklık düzenleyici ve sinirsel koruyucu etkiye sahip yeni 1,5- ve 3-O-ikameli 1H-indazoller, bunların hazırlanması ve tıbbi maddeler olarak kullanımları.
HUP0001093A3 (en) Oxazolidines as 5-ht2a-antagonists, pharmaceutical compositions containing the same and process for their preparation
MY120550A (en) Substituted 1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocin-10-ols, processes for preparing them and their use as pharmaceutical compositions.
HK1024695A1 (en) Novel counterparts of camptothecin, their application as medicine and pharmaceutical compositions containing them
AU5139596A (en) Pharmaceutical matrix pellets, tablets and composition for the preparation thereof
MD970269A (en) Clavulanates
GEP20012518B (en) Novel Erythromycin Derivatives, Method for Their Preparation and Their Use as Medicine
AU1606997A (en) Novel naphthylpiperazines derived from substituted cycloazanes, method for preparing same, pharmaceutical compositions and use thereof as drugs
TR200100801T2 (tr) Benzoilguanidin türevleri, imalatlarına yönelik yöntemler, ilaç yapımında kullanımı
HUP9701093A1 (hu) Huminsavtartalmú gyógyászati készítmény